Cite
HARVARD Citation
Dultz, G. et al. (2015). Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis. Alimentary pharmacology & therapeutics. 41 (5), pp. 459-466. [Online].